http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3818095-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-06 |
| filingDate | 1972-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1974-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a32315d56215c4cb53a8d5859fd9b512 |
| publicationDate | 1974-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-3818095-A |
| titleOfInvention | Compositions of 1,2-dilower alkyl-3(and/or4)-aryl-3-pyrazolines and salts thereof and method of lowering blood sugar levels with same |
| abstract | Pharmaceutical compositions containing as active component a 1,2-dilower alkyl-3(and/or 4)-aryl-3-pyrazoline, or an acid addition salt or a quaternary salt thereof are described, along with methods of using same. These active components exhibit hypoglycemic activity as evidenced by their ability to lower blood sugar levels. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109970649-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109970649-B |
| priorityDate | 1972-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 84.